{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "EFFECTOR THERAPEU. CL.A", "longName": "eFFECTOR Therapeutics, Inc.", "messageBoardId": "finmb_240590335", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": 6.008583, "regularMarketPrice": 0.494, "marketState": "REGULAR", "fiftyTwoWeekHighChangePercent": -0.75784314, "fiftyTwoWeekLow": 0.302, "fiftyTwoWeekHigh": 2.04, "earningsTimestamp": 1683662463, "earningsTimestampStart": 1691405940, "earningsTimestampEnd": 1691755200, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.53, "sharesOutstanding": 42401200, "bookValue": 0.093, "fiftyDayAverage": 0.39156, "fiftyDayAverageChange": 0.10244, "fiftyDayAverageChangePercent": 0.2616202, "twoHundredDayAverage": 0.502715, "twoHundredDayAverageChange": -0.008715004, "twoHundredDayAverageChangePercent": -0.017335873, "marketCap": 20946192, "priceToBook": 5.3118277, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "priceHint": 4, "regularMarketChange": 0.027999997, "regularMarketTime": 1683875702, "regularMarketDayHigh": 0.494, "regularMarketDayRange": "0.494 - 0.494", "regularMarketDayLow": 0.494, "regularMarketVolume": 4141, "regularMarketPreviousClose": 0.466, "bid": 0.4885, "ask": 0.508, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 0.494, "averageDailyVolume3Month": 118, "averageDailyVolume10Day": 414, "fiftyTwoWeekLowChange": 0.192, "fiftyTwoWeekLowChangePercent": 0.6357616, "fiftyTwoWeekRange": "0.302 - 2.04", "fiftyTwoWeekHighChange": -1.546, "firstTradeDateMilliseconds": 1632722400000, "symbol": "LWK1.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "142 North Cedros Avenue", "address2": "Suite B", "city": "Solana Beach", "state": "CA", "zip": "92075", "country": "United States", "phone": "858 925 8215", "website": "https://effector.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer. The company is also developing zotatifin, a small molecule designed to inhibit eukaryotic initiation factor 4A (eIF4E), which is in Phase 1/2 clinical trial to treat patients with solid tumors and in combination with fulvestrant and abemaciclib in a Phase 2a open-label expansion cohort to treat patients with ER+ breast cancer. eFFECTOR Therapeutics, Inc. has a research collaboration and license agreement with Pfizer Inc. to develop inhibitors of eIF4E. eFFECTOR Therapeutics, Inc. was incorporated in 2012 and is headquartered in Solana Beach, California.", "fullTimeEmployees": 15, "companyOfficers": [{"maxAge": 1, "name": "Dr. Stephen T. Worland Ph.D.", "age": 64, "title": "CEO, Pres & Director", "yearBorn": 1958, "fiscalYear": 2022, "totalPay": {"raw": 855255, "fmt": "855.25k", "longFmt": "855,255"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Michael  Byrnes M.B.A.", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1977, "fiscalYear": 2022, "totalPay": {"raw": 623690, "fmt": "623.69k", "longFmt": "623,690"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Douglas  Warner M.D.", "age": 50, "title": "Chief Medical Officer", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": {"raw": 304400, "fmt": "304.4k", "longFmt": "304,400"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Siegfried  Reich Ph.D.", "age": 62, "title": "Co-Founder and Member of Clinical & Scientific Advisory Board", "yearBorn": 1960, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Davide  Ruggero Ph.D.", "title": "Co-Founder and Member of Clinical & Scientific Advisory Board", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Kevan M. Shokat Ph.D.", "title": "Co-Founder and Member of Clinical & Scientific Advisory Board", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Mayank J. Gandhi M.D.", "age": 44, "title": "Chief Bus. Officer", "yearBorn": 1978, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}